Form D · Biotechnology
ICaPath, Inc.
Morgantown, WV · CIK 0001872808
Offering snapshot reported Sep 15, 2022 · SEC filing
- Reported sold
- $650K Offering amount: $650K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2022 | Initial | $650,000 | No comparison | 3 | SEC filing |
| Oct 25, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-458986
Source: Form D, filed Sep 15, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brock Lindsey | Director, Executive |
| Steven Norch | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
118 Stone Brook Estates
Morgantown, WV, 26508
Morgantown, WV, 26508